10 Dec 2020
*A corporate client of Hybridan LLP
Dish of the day
No joiners today.
Off the menu
Cancellation of Tri-Star Resources on AIM
What’s cooking in the IPO kitchen?
Intuitive Investments Group, a closed-end investment company focussed on the life sciences sector, announces its intention to seek admission the AIM market of the London Stock Exchange plc, and a conditional placing , at a price of 20 pence per share, to raise gross proceeds of £7.5 million . · The net proceeds of the Placing will be used by the Company:- to invest in fast growing and / or high potential life sciences businesses, based predominantly in the UK, wider Europe and the US, chosen from an identified pipeline of investment opportunities – investments will be focused on diagnostics and healthcare, medical devices, tools and technologies and bio-therapeutics and pharmaceuticals · The market capitalisation of the Company is expected to be circa £7.8 million on Admission. Due 14 Dec.
Schroder BSC Social Impact Trust plc targeting a £100m raise. The Company’s investment objective is to be the first London listed investment company to deliver measurable positive social impact as well as long term capital growth and income, through investing in a diversified portfolio of private market impact funds, co-investments alongside impact investors and direct investments in order to gain exposure to private market Social Impact Investments. Due 22 Dec. Official List (premium)
Abingdon Health to list on AIM. Abingdon Health is a lateral flow diagnostics company providing contract service solutions to a global client base in the healthcare sector and other industries . The Company has developed and is manufacturing the AbC-19TM Rapid Test, an antibody test for Covid-19 indicating whether a person is generating IgG antibodies to the spike protein of the SARS-CoV-2 virus. The Company is also working with three customers to transfer their Covid-19 antigen tests to manufacture, and is manufacturing a component of a rapid PCR (polymerase chain reaction) test. Offer TBC. Due early Dec.
Downing Renewables & Infrastructure Trust intends to raise up to £200 million to target the acquisition of a diversified portfolio of renewable energy and other infrastructure assets and list on the Official List of the Financial Conduct Authority and Main Market of the London Stock Exchange . Due by mid December
Ecofin U.S. Renewables Infrastructure Trust. Initial public offering of up to us$250 million to invest in a diversified portfolio of mixed US renewable energy assets with an attractive long-term income stream. Main market premium. Due 14 Dec
VH Global Sustainable Energy Opportunities plc, a closed-ended investment company focused on making sustainable energy infrastructure investments, today announces intends to launch an initial public offering of shares on the Official List (Premium) of the Financial Conduct Authority and Main Market of the London Stock Exchange. Due by Early Feb 2021
Tirupati Graphite, the fully-integrated, cash generative, specialist graphite and graphene producer with operations in Madagascar and India, announced its potential intention to undertake an initial public offering on the LSE (standard listing). Raising £6m. Mkt cap c.£33.6m. Due 14 December
Bytes Technology Group one of the UK’s leading software, security and cloud services specialists, announces that the Company intends to publish a Registration Document and is considering proceeding with an initial public offering (Main Mkt Prem). FY20 gross profit of £79.2m (+24.5% against FY19) and adjusted operating profit of £31.7m (+53.9% against FY19). Highly cash generative with FY20 cash conversion of 125.9% (FY19 cash conversion 139.7%). Bytes due on or around 17 December 2020.
Mailbox REIT PLC , a newly formed single asset company which owns the Mailbox , a large prime office-led mixed use property in Birmingham which has been independently valued at £179m, announced its intention to raise up to £62.5m. MailBox REIT will apply for the Ordinary Shares be admitted to trading on the IPSX Prime segment of International Property Securities Exchange (IPSX ). Due 14 December.
Umuthi Healthcare Solutions Plc, the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas, seeking admission to the Standard Listing segment of the Official List. Timing tbc
Kibo Energy PLC, the multi-asset Africa focused energy Company, is seeking admission for its 100% owned UK subsidiary Sloane Developments Ltd , which will be renamed Mast Energy Developments PLC (MED), to the Standard List of the London Stock Exchange plc. The MED business strategy is to acquire and develop a portfolio of flexible small-scale power generation assets, exploiting a growth niche market in the UK for Reserve Power generation to balance out the national grid at critical times. Timing TBC
Zephyr Energy 0.75p £5.22m (LON:ZPHR)
The Rocky Mountain oil and gas company focused on responsible resource development, updated on its project in the Paradox Basin, Utah, U.S. where it is in the final stages of preparation ahead of the spud of its ‘dual-use’ State 16-2 well.
The Company initially targeted a spud date by 31 December – and it remains firmly on track to deliver this key corporate objective. Over the last two months, the Company made significant progress on important milestones to ensure that it can safely deliver a successful well on time and within budget. During this period, the Company:
· Assembled a project drilling team with substantial Paradox Basin drilling expertise; Secured all permits and satisfied all pre-operational conditions; Completed remediation works on the road leading to the State 16-2 site; Finished all other site preparations, including the completion of work to responsibly plug and permanently abandon an existing inactive well on the pad; Awarded the rig contract to Cyclone Drilling Inc. (“Cyclone”), a leading provider of purpose-built rigs in the Rocky Mountain region. The specific rig under contract is Cyclone Rig #34; and, Received the first $600,000 tranche of grant funds allocated by the U.S Department of Energy and its National Energy Technology Laboratory for the drilling of the well.
Corero Network Security 9.5p £47m (LON:CNS)
The provider of real-time, high-performance, automatic Distributed Denial of Service (DDoS) defence solutions , announces that it continues to make further progress towards its strategic goals of international expansion, development of its strategic and business partnerships and further penetration of Tier 1 and major accounts. This positive progression is reflected in the associated order intake of more than $3 million in the first two months of the final quarter of 2020. Revenues associated with these orders will be recognised over the course of the lifetime of each of the contracts.
Quixant 149p £99m (LON:QXT)
The provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, provides the following update on trading for the current financial year, ending 31 December 2020. Since the release of the Group’s interim results on 30 September 2020, trading in its core gaming market has exceeded expectations. As a result, the Group now expects to report full year adjusted profit before tax of at least $1m on revenue of at least $61m.
Active Energy 0.575p £8.9m (LON:AEG)
The international biomass based renewable energy and forestry management business has been awarded a new U.S. patent for its CoalSwitch™ process and the beneficiation of biomass. The patent, number 10,858,607, was awarded on 8 December 2020 and will ensure Active Energy holds the legal rights to exclude any other company from producing, selling or using the claimed CoalSwitch™ process for over 17 years. The proprietary CoalSwitch™ process includes subjecting steam-exploded biomass to a second washing step to remove additional salts and light volatile compounds derived from the biomass.
This new patent combines with the U.S. process patent, number 10,647,935, which was awarded for AEG’s PeatSwitch™ technology on 12 May 2020. AEG’s PeatSwitch™ patent gives AEG the exclusive rights over the process of producing an engineered soil from raw biomass in AEG’s unique reactor.
The Company continues to file further patent applications in the US and will follow each of these with additional filings in Canada, Malaysia, Thailand and Europe.
NetScientific 49.5p £7.38m (LON:NSCI)
The life sciences, technology, investment and commercialisation company, announces that its portfolio company ProAxsis Limited, has been awarded a high impact Innovate UK grant as part of the recent “UKRI Ideas to Address COVID-19” competition. The company will immediately initiate the £390,000 project, which will be co-funded by Innovate UK, to develop novel protease biomarkers to identify high-risk patients.
ProAxsis is established at the forefront of respiratory diagnostics, with clients in the Pharma and clinical trials markets. Its R&D pipeline is reinforcing this position by expanding the applicability of its technology – including around the use of its biomarkers platform to help in the fight against COVID-19.
RBD announced results of the West Newton B drilling operations, which have exceeded pre-drill expectations, further suggesting that the West Newton discovery would be the largest UK onshore discovery since 1973. Drilling operations have been completed safely.
B-1Z well encountered a gross 62 metre hydrocarbon bearing reservoir interval in the primary Kirkham Abbey target formation. Overall Kirkham Abbey estimated hydrocarbon column is at least 118 metres, significantly exceeding previous observations. The oil-water contact is yet to be encountered at West Newton. Enhanced porosities of over 14 per cent. observed on wireline logs, comparing favourably to previous A-2 well. The Kirkham Abbey formation is materially de-risked with evidence of good reservoir continuity. West Newton B-1Z is approximately 2.5 kilometres from the A-1 and A-2 discoveries. Production casing is being run in preparation for well testing.
Induction Healthcare 78p £32.8m (LON:INHC)
The healthcare technology company that helps achieve digital efficiencies for hospitals, their front-line clinicians and patients, announces results for the six months ended 30 September 2020.
· First full year of revenue · Strong momentum in sales and Annual Recurring Revenue (ARR) run rate across all its subscription-based software products · Revenues of £0.6m, includes first revenue generated by Induction Switch (as previously indicated) · Robust balance sheet, with net cash of £5.0 million; prudent management of costs and cashflow · Deferred revenue at £0.6m (H1 2020: nil)
· Strong pipeline of orders with multi-year contracts· Healthy acquisition pipeline targeting new and complementary products and geographies, supporting the strategy to add solutions that deliver value to patients, doctors and other clinicians · Growth of registered users and user engagement across Induction’s product suite, and progress with key frameworks and collaborations such as NHSX Clinical Communication Framework and Cerner creates a strong foundation for continued growth in recurring revenue in the year ahead.
UK Oil & Gas 0.1425p £17.8m (LON:UKOG)
Together with its 50-50 Turkish joint venture partner, Aladdin Middle East (AME), the Company has applied to the Turkish authorities for three further exploration licences in south east Turkey. The application area covers four c. 150 km² blocks lying to the south and south east of the Company’s 305 km² Basur-Resan Licence (see RNS releases of July 23 and October 13, 2020). This application is on a ground floor basis with UKOG responsible solely for its 50% share of any future costs.
The four blocks straddle multiple large identified undrilled surface geological features (i.e. surface anticlines), each geologically similar to the Company’s Basur-Resan oil appraisal project, AME’s producing East Sadak oil field and the Kurdistan Region of Iraq’s oil fields to the south. To date, the application blocks have been scantily explored with almost no seismic coverage and few wells.
Thor Mining 0.975p £14.8m (LON:THR)
Identification of a number of significant magnetic targets following the interpretation, of the Airborne magnetics survey flown in October 2020, at the 100% owned Ragged Range Project in Western Australia.
· Sterling Prospect, identified as the principle initial target, is approximately five kilometres long & between 300 and 500 metres in width; Anomalous stream sediment gold assays (up to 2.2g/t Au) clearly related to the structural contact of the Euro Basalt and younger Dalton Suite, at the Sterling Prospect. Gold present in streams confirms that gold mineralisation occurs very close to surface. (ASX/AIM: THR 1 December 2020); Three isolated, strong magnetic anomalies, highlighted on the geological maps with links below, have no simple geological explanation in the magnetics. These are priority targets for follow-up;
The Ragged Range area is structurally complex with many phases of folding and shortening of the prospective Euro Basalt. This leads to the creation of space, significantly increasing the potential to host gold mineralisation.
GYG 69.5p £32.4m (LON:GYG)
The market leading superyacht painting, supply and maintenance company, announced the signing of a Refit contract for a 100+ metre yacht.
The work is scheduled to commence in Europe in 2022, further improving the forward visibility of the Order Book, which remains at record levels, including eight New Build projects for delivery in the next two years. This is another significant turnkey project for the Group, utilising the Refit services including bespoke scaffolding, containment, hardware removal, caulking and complete repainting. It follows the recently announced signing of a 115+ metre yacht in Germany which is due to complete in H121.
“This contract highlights our increasing average order value as a result of our market leading position in the premium 70m+ yacht market, as well as the turnkey range of global services we are able deploy at scale on vessels which are increasingly complex in nature.”
0203 764 2344
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of section B of annex I to Directive 2014/65/EU (“MIFID II Directive”); or (ii) investment research as defined in article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.